Royalty Pharma PlcRPRX
▲ PositiveCapitalrelevance
Company declares a quarterly dividend, a direct financial event returning capital to shareholders.

Royalty Pharma's board of directors has approved a third-quarter 2026 dividend of $0.235 per Class A ordinary share. The dividend will be paid on September 10, 2026, to shareholders of record as of the close of business on August 14, 2026.
Royalty Pharma PlcCompany declares a quarterly dividend, a direct financial event returning capital to shareholders.